Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Abivax S.A.

CIK 1956827Updated Nov 17, 2026

AAVXF price & chart

Provider market data

Loading TradingView…

OTC:AAVXF on TradingView ↗

TradingView · Data may be delayed

About the company

Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Based in France and the United States, Abivax’s lead drug candidate, obefazimod (ABX464), is in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis.

6-K · 2026-06-29 · 0001193125-26-288752

Company description from the cited filing.

Financials

FY 2025 · EUR
Revenue— · FY 2025
Net income— · FY 2025
Assets—EUR · FY 2025
Cash— · FY 2025
Operating income-246,056,000EUR · FY 2025
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

Diluted EPS-4.83EUR/shares · FY 2025
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

Balance-sheet figures are unavailable pending verification.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2025Q2 2024Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Profit or LossEUR——-153,358,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

-55,227,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

-48,414,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

-38,771,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

-52,370,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

-42,867,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

-336,102,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

-176,242,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

-147,740,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

-60,740,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

Additional Financial Items
AdjustmentsForIncomeTaxExpenseEUR————————5,848,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

———
AdjustmentsForIncreaseDecreaseInTradeAccountPayableEUR——————12,754,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

5,199,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

-6,210,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

-3,444,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

31,757,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

-2,388,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

AdjustmentsForSharebasedPaymentsEUR——————4,689,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

5,755,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

35,397,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

20,224,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

8,179,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

-1,164,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

GeneralAndAdministrativeExpenseEUR——25,500,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

7,375,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

8,270,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

9,796,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

8,033,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

8,136,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

67,670,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

32,946,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

22,390,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

7,492,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

GoodwillEUR——18,419,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

As of 2025-09-30

—18,419,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

As of 2025-06-30

—18,419,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

As of 2025-03-31

—18,419,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

As of 2025-12-31

18,419,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

As of 2024-12-31

18,419,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

As of 2023-12-31

18,419,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

As of 2022-12-31

IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesEUR————————0
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

———
IncreaseDecreaseInWorkingCapitalEUR——————-9,011,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

-3,921,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

-3,651,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

-1,423,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

-21,265,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

2,002,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

InterestPaidClassifiedAsFinancingActivitiesEUR——————1,965,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

1,070,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

6,490,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

7,696,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

5,279,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

4,015,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesEUR——————230,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

143,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

911,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

458,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

529,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

301,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

ProceedsFromBorrowingsClassifiedAsFinancingActivitiesEUR————————175,000,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2013-12-04 to 2025-12-31

—125,000,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2013-12-04 to 2023-12-31

—
ProceedsFromIssuingSharesEUR————————648,124,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

0
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

353,377,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

46,231,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesEUR————————0
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

3,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

0
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

35,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2025Q2 2024Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
Additional Financial Items
ApplicableTaxRatenumber————————0.25
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

0.25
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

——
BasicEarningsLossPerShareEUR/shares——-2.1
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

-0.87
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

-0.76
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

-0.62
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

-0.83
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

-0.68
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

-4.83
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

-2.8
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

-3.43
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

-3.18
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

DilutedEarningsLossPerShareEUR/shares——-2.1
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

-0.87
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

-0.76
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

-0.62
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

-0.83
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

-0.68
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

-4.83
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

-2.8
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

-3.43
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

-3.18
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

FinanceCostsEUR——93,051,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

8,474,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

5,415,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

7,056,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

6,723,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

4,228,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

111,743,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

16,991,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

27,875,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

7,022,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

FinanceIncomeEUR——20,404,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

3,436,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

3,497,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

3,612,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

1,552,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

6,031,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

27,545,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

13,732,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

7,511,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

11,118,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

GeneralAndAdministrativeExpenseEUR——25,500,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

7,375,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

8,270,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

9,796,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

8,033,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

8,136,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

67,670,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

32,946,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

22,390,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

7,492,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

IncomeTaxExpenseContinuingOperationsEUR——0
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

0
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

0
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

0
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

0
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

0
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

5,848,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

0
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

0
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

0
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

InterestExpenseOnLeaseLiabilitiesEUR——15,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

18,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

17,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

20,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

19,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

5,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

64,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

61,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

13,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

10,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

OtherFinanceCostEUR——8,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

15,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

——6,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

5,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

29,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

64,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

73,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

83,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

OtherIncomeEUR——2,043,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

1,324,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

1,093,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

5,628,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

994,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

1,186,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

4,570,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

12,449,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

4,621,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

4,583,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

ProfitLossBeforeTaxEUR——-153,358,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

-55,227,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

-48,414,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

-38,770,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

-52,370,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

-42,867,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

-330,254,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

-176,242,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

-147,740,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

-60,740,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

ProfitLossFromOperatingActivitiesEUR——-80,712,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

-50,189,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

-46,496,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

-35,326,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

-47,200,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

-44,671,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

-246,056,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

-172,984,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

-127,376,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

-64,836,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

ResearchAndDevelopmentExpenseEUR——55,416,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

43,286,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

38,645,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

28,907,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

39,301,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

35,744,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

177,761,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

146,532,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

103,176,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

48,295,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

RevenueFromInterestEUR——3,361,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2025-07-01 to 2025-09-30

1,983,000
Source

6-K · 2025-12-15 · 0001956827-25-000035

2024-07-01 to 2024-09-30

190,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2025-04-01 to 2025-06-30

2,277,000
Source

6-K · 2025-09-08 · 0001956827-25-000031

2024-04-01 to 2024-06-30

859,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2025-01-01 to 2025-03-31

2,534,000
Source

6-K · 2025-06-02 · 0001956827-25-000021

2024-01-01 to 2024-03-31

5,600,000
Source

20-F · 2026-03-23 · 0001956827-26-000012

2025-01-01 to 2025-12-31

8,246,000
Source

20-F · 2025-03-24 · 0001956827-25-000010

2024-01-01 to 2024-12-31

2,418,000
Source

20-F · 2024-04-05 · 0001956827-24-000007

2023-01-01 to 2023-12-31

0
Source

20-F · 2024-04-05 · 0001956827-24-000007

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

d86113dex44.htm · POSASR · 2026-06-30

Exhibit 4.4 ABIVAX SA, as Issuer AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of ______, 20__ Debt Securities TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section 1.01 …

POSASR · 2026-06-30 · 0001193125-26-290578

Read attachment ↗
d110874dex991.htm · 6-K · 2026-06-29

Exhibit 99.1 Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database Obefazimod delivered meaningful clinical benefit in a highly refractory ulcerative colitis (“UC”) population, with 37.2% of induction non-responders achieving clinical remission and 34.5% achieving endoscopic remission at Week 44 following continued 50 mg treat…

6-K · 2026-06-29 · 0001193125-26-288752

Read attachment ↗
d98688dex991.htm · 6-K · 2026-06-02

Exhibit 99.1 Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis At Week 44, both the 25 mg and 50 mg once-daily obefazimod doses met the primary endpoint, demonstrating placebo-adjusted clinical remission rates of ∆39.3% and ∆40.3%, respectively (25 mg: 50.8%, 50 mg: 51.3% vs placebo 10.4%; p<0.0001) Both 25 mg and 50 mg obefazimod met all key secondary endpoints, demonstrating robust and clinica…

6-K · 2026-06-02 · 0001193125-26-252360

Read attachment ↗
d148287dex991.htm · 6-K · 2026-05-07

Exhibit 99.1 Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares Cash runway remains into Q4 2027, supporting continued funding of clinical programs and pre-commercial planning activities ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Royalty overhang materially reduced, enhancing financial flexibility to support future commercialization …

6-K · 2026-05-07 · 0001193125-26-211853

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.